{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_882426", "regularMarketChangePercent": -1.727669, "regularMarketPrice": 6.8201, "exchange": "NCM", "shortName": "Liminal BioSciences Inc.", "longName": "Liminal BioSciences Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1261146600000, "priceHint": 2, "regularMarketChange": -0.11990023, "regularMarketTime": 1684176683, "regularMarketDayHigh": 6.95, "regularMarketDayRange": "6.82 - 6.95", "regularMarketDayLow": 6.82, "regularMarketVolume": 3414, "regularMarketPreviousClose": 6.94, "bid": 0.0, "ask": 0.0, "bidSize": 10, "askSize": 11, "fullExchangeName": "NasdaqCM", "financialCurrency": "CAD", "regularMarketOpen": 6.95, "averageDailyVolume3Month": 159983, "averageDailyVolume10Day": 7810, "fiftyTwoWeekLowChange": 3.7201, "fiftyTwoWeekLowChangePercent": 1.2000322, "fiftyTwoWeekRange": "3.1 - 7.06", "fiftyTwoWeekHighChange": -0.23990011, "fiftyTwoWeekHighChangePercent": -0.033980187, "fiftyTwoWeekLow": 3.1, "fiftyTwoWeekHigh": 7.06, "dividendDate": 1562284800, "earningsTimestamp": 1683662713, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -7.1, "epsForward": -8.82, "epsCurrentYear": -8.11, "priceEpsCurrentYear": -0.8409495, "sharesOutstanding": 3104220, "bookValue": 11.664, "fiftyDayAverage": 5.70758, "fiftyDayAverageChange": 1.1125197, "fiftyDayAverageChangePercent": 0.19491969, "twoHundredDayAverage": 4.931755, "twoHundredDayAverageChange": 1.8883448, "twoHundredDayAverageChangePercent": 0.38289508, "marketCap": 21171090, "forwardPE": -0.773254, "priceToBook": 0.58471364, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "displayName": "Liminal BioSciences", "symbol": "LMNL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "440 Armand-Frappier Boulevard", "address2": "Suite 300", "city": "Laval", "state": "QC", "zip": "H7V 4B4", "country": "Canada", "phone": "450 781 0115", "fax": "450 781 4477", "website": "https://www.liminalbiosciences.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company is developing LMNL6511, a selective antagonist for the G-protein coupled receptor 84, is expected to commence a Phase 1 clinical trial. It is also developing potential OXER1 antagonists and GPR40 agonists, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Bruce  Pritchard BA, CA, FIOD", "age": 48, "title": "Chief Exec. Officer", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 698944, "fmt": "698.94k", "longFmt": "698,944"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrick  Sartore", "age": 47, "title": "Pres", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 613823, "fmt": "613.82k", "longFmt": "613,823"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gary J. Bridger Ph.D.", "age": 59, "title": "Interim Chief Scientific Officer & Non-Independent Director", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 264690, "fmt": "264.69k", "longFmt": "264,690"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marie  Iskra L.L.B.", "age": 45, "title": "Corp. Sec. & Gen. Counsel", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": {"raw": 435822, "fmt": "435.82k", "longFmt": "435,822"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. N. Nicole Rusaw C.A., CPA", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Shrinal  Inamdar", "title": "Mang. of Investor Relations & Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Steven J. Burton", "title": "Pres of Prometic Bioseparations Ltd", "fiscalYear": 2003, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 1, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}